Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 200

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

HIV Infection and Survival Among Women With Cervical Cancer

Open access
Dryden-Peterson, Scott, Bvochora-Nsingo, Memory, Suneja, Gita, Efstathiou, Jason A., Grover, Surbhi, Chiyapo, Sebathu, Ramogola-Masire, Doreen, Kebabonye-Pusoentsi, Malebogo, Clayman, Rebecca, Mapes, Abigail C., Tapela, Neo, Asmelash, Aida, Medhin, Heluf, Viswanathan, Akila N., Russell, Anthony H., Lin, Lilie L., Kayembe, Mukendi K.A., Mmalane, Mompati, Randall, Thomas C., Chabner, Bruce, Lockman, Shahin·2016·Journal of Clinical Oncology

Abstract

Purpose: Cervical cancer is the leading cause of cancer death among the 20 million women with HIV worldwide. We sought to determine whether HIV infection affected survival in women with invasive cervical cancer. Patients and Methods: We enrolled sequential patients with cervical cancer in Botswana from 2010 to 2015. Standard treatment included external beam radiation and brachytherapy with concurrent cisplatin chemotherapy. The effect of HIV on survival was estimated by using an inverse probability weighted marginal Cox model. Results: A total of 348 women with cervical cancer were enrolled, including 231 (66.4%) with HIV and 96 (27.6%) without HIV. The majority (189 [81.8%]) of women with HIV received antiretroviral therapy before cancer diagnosis. The median CD4 cell count for women with HIV was 397 (interquartile range, 264 to 555). After a median follow-up of 19.7 months, 117 (50.7%) women with HIV and 40 (41.7%) without HIV died. One death was attributed to HIV and the remaining to cancer. Three-year survival for the women with HIV was 35% (95% CI, 27% to 44%) and 48% (95% CI, 35% to 60%) for those without HIV. In an adjusted analysis, HIV infection significantly increased the risk for death among all women (hazard ratio, 1.95; 95% CI, 1.20 to 3.17) and in the subset that received guideline-concordant curative treatment (hazard ratio, 2.63; 95% CI, 1.05 to 6.55). The adverse effect of HIV on survival was greater for women with a more-limited stage cancer ( P = .035), those treated with curative intent ( P = .003), and those with a lower CD4 cell count ( P = .036). Advanced stage and poor treatment completion contributed to high mortality overall. Conclusion: In the context of good access to and use of antiretroviral treatment in Botswana, HIV infection significantly decreases cervical cancer survival.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2016.67.9613

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 200

Metadata

Authors
Dryden-Peterson, S., Bvochora-Nsingo, M., Suneja, G., Efstathiou, J. A., Grover, S., Chiyapo, S., Ramogola-Masire, D., Kebabonye-Pusoentsi, M., Clayman, R., Mapes, A. C., Tapela, N., Asmelash, A., Medhin, H., Viswanathan, A. N., Russell, A. H., Lin, L. L., Kayembe, M. K. A., Mmalane, M., Randall, T. C., Chabner, B., & Lockman, S.
Venue
Journal of Clinical Oncology
Published
2016-11-01
Volume
34
Issue
31
Pages
3749-3757
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2518457568
Cited by
200
References
1
FWCI
13.63
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HIV Infection and Survival Among Women With Cervical Cancer. https://app.cochat.ai/papers/10.1200/jco.2016.67.9613
The paper
Dryden-Peterson, S., Bvochora-Nsingo, M., Suneja, G., Efstathiou, J. A., Grover, S., Chiyapo, S., Ramogola-Masire, D., Kebabonye-Pusoentsi, M., Clayman, R., Mapes, A. C., Tapela, N., Asmelash, A., Medhin, H., Viswanathan, A. N., Russell, A. H., Lin, L. L., Kayembe, M. K. A., Mmalane, M., Randall, T. C., . . . Lockman, S. (2016). HIV Infection and Survival Among Women With Cervical Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2016.67.9613

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.